Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease. (2017) Chiriac MT, Buchen B, Wandersee A, Hundorfean G, Günther C, Bourjau Y, Doyle SE, et al. Journal article The Effects of a Normal Rate versus a Slow Intervalled Rate of Oral Nutrient Intake and Intravenous Low Rate Macronutrient Application on Psychophysical Function - Two Pilot Studies (2017) Denzer-Lippmann M, Bachlechner S, Wielopolski J, Fischer M, Büttner A, Dörfler A, Schöfl C, et al. Journal article Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease. (2017) Pfeifle R, Rothe T, Ipseiz N, Scherer HU, Culemann S, Harre U, Ackermann J, et al. Journal article Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps (2017) Kienhofer D, Hahn J, Stoof J, Csepregi JZ, Reinwald C, Urbonaviciute V, Johnsson C, et al. Journal article The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update (2017) Catassi C, Alaedini A, Bojarski C, Bonaz B, Bouma G, Carroccio A, Castillejo G, et al. Journal article Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease (2017) Atreya R, Neurath M Journal article Crohn's disease - use of biomarkers in general practice (2017) Vetter M, Neurath MF, Atreya R Journal article Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease (2017) Martini E, Krug SM, Siegmund B, Neurath M, Becker C Journal article Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4 (2017) Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, et al. Journal article Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017) Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al. Journal article